Allergan’s Botox Gains Continue, Pipeline Progresses Ahead Of AbbVie Merger

 
• By Mandy Jackson
  
Progress, planning strategy, rise in sales or success in business concept. Future prediction and estimation with high expectations. Development and improvement. Growing graph. Hand stacking tiles. - Image
Allergan's Q3 revenue increased 3.6% to $4.05bn, beating expectations. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business